Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

VISKViskase Holdings, Inc.

OTC · CIK 0000727510
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts443

Identity from submissions API

NameViskase Holdings, Inc.
CIK0000727510
TickersVISK
ExchangesOTC
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN222372868
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(630) 874-0700
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • ENZON PHARMACEUTICALS, INC. (2016-03-21T04:00:00.000Z → 2026-03-25T04:00:00.000Z)
  • ENZON PHARMACEUTICALS INC (2006-03-29T05:00:00.000Z → 2016-02-23T05:00:00.000Z)
  • ENZON PHARMACEUTICALS INC (2002-12-13T05:00:00.000Z → 2006-03-22T05:00:00.000Z)
  • ENZON PHARMACEUTICAL INC (2002-12-10T05:00:00.000Z → 2002-12-10T05:00:00.000Z)
  • ENZON INC (1995-10-26T04:00:00.000Z → 2002-12-09T05:00:00.000Z)
Business address
333 EAST BUTTERFIELD ROAD, SUITE 400
LOMBARD
IL
60148
IL
Mailing address
333 EAST BUTTERFIELD ROAD, SUITE 400
LOMBARD
IL
60148
IL

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

No Financialist filing articles yet for this CIK.

SEC filings

1517 filing rows loaded from submissions recent; extra archives: CIK0000727510-submissions-001.json (517 filings, 1995-03-03 to 2004-11-15).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-03 10-Q 10-Q 0001104659-26-121529 000-12957 261513888 34 12763906 1 1
2026-08-03 10-Q 10-Q 0001104659-26-089804 000-12957 261233083 34 12340251 1 1
2026-05-05 8-A12G 8-A12G 0001104659-26-055637 000-12957 26943302 34 44845
2026-05-05 8-K FORM 8-K 1.01,3.03,5.03,7.01,9.01 0001104659-26-055632 000-12957 26943185 34 756465 1 1
2026-05-04 10-Q 10-Q 0001104659-26-054911 000-12957 26937845 34 9385093 1 1
2026-05-01 3 OWNERSHIP DOCUMENT 0001104659-26-053545 17698
2026-05-01 8-K/A FORM 8-K/A 9.01 0001104659-26-053523 000-12957 26929095 34 1803431 1 1
2026-05-01 8-K FORM 8-K 5.02 0001104659-26-053522 000-12957 26929091 34 192047 1 1
2026-04-29 10-K/A 10-K/A 0001104659-26-051643 000-12957 26917541 34 708604 1 1
2026-04-21 8-K FORM 8-K 1.01,2.03,9.01 0001104659-26-046064 000-12957 26880047 34 1869098 1 1
2026-04-16 8-K FORM 8-K 4.01,9.01 0001104659-26-044420 000-12957 26868056 34 203372 1 1
2026-04-15 8-K FORM 8-K 5.02 0001104659-26-043811 000-12957 26864358 34 186207 1 1
2026-03-27 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001012975-26-000274 14700
2026-03-27 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001193125-26-129970 005-35587 26809553 34 12805
2026-03-26 3 OWNERSHIP DOCUMENT 0001104659-26-035420 21225
2026-03-26 3 OWNERSHIP DOCUMENT 0001104659-26-035418 3404
2026-03-26 3 OWNERSHIP DOCUMENT 0001104659-26-035417 19732
2026-03-26 3 OWNERSHIP DOCUMENT 0001104659-26-035416 3396
2026-03-26 3 OWNERSHIP DOCUMENT 0001104659-26-035415 3402
2026-03-26 3 OWNERSHIP DOCUMENT 0001104659-26-035414 19689
2026-03-26 3 OWNERSHIP DOCUMENT 0001104659-26-035413 20530
2026-03-26 3 OWNERSHIP DOCUMENT 0001104659-26-035411 19144
2026-03-26 3 OWNERSHIP DOCUMENT 0001104659-26-035410 18866
2026-03-26 3 OWNERSHIP DOCUMENT 0001104659-26-035409 19726
2026-03-26 3 OWNERSHIP DOCUMENT 0001104659-26-035408 20156
2026-03-26 3 OWNERSHIP DOCUMENT 0001104659-26-035407 3424
2026-03-26 3 OWNERSHIP DOCUMENT 0001104659-26-035406 3507
2026-03-26 8-K FORM 8-K 2.01,3.02,5.01,5.02,5.03,7.01,9.01 0001104659-26-035301 000-12957 26799558 34 252273 1 1
2026-03-25 425 425 0001104659-26-034194 000-12957 26788501 34 22547
2026-03-25 8-K FORM 8-K 7.01,9.01 0001104659-26-034187 000-12957 26788495 34 183932 1 1
2026-03-25 SC TO-I/A SC TO-I/A 0001104659-26-034177 005-35587 26788486 34 26692
2026-03-24 SC TO-I/A SC TO-I/A 0001104659-26-033627 005-35587 26784280 34 20418
2026-03-24 8-A12G/A 8-A12G/A 0001104659-26-033626 000-12957 26784277 34 39768
2026-03-24 425 425 0001104659-26-033625 000-12957 26784275 34 85863
2026-03-24 8-K FORM 8-K 1.01,3.03,5.03,7.01,9.01 0001104659-26-033624 000-12957 26784271 34 269022 1 1
2026-03-19 425 425 0001104659-26-032098 000-12957 26774479 34 29529
2026-03-19 8-K FORM 8-K 7.01,9.01 0001104659-26-032092 000-12957 26774439 34 193969 1 1
2026-03-19 SC TO-I/A SC TO-I/A 0001104659-26-032068 005-35587 26774294 34 41393
2026-03-18 8-A12G/A 8-A12G/A 0001104659-26-029974 000-12957 26765834 34 35445
2026-03-18 425 425 0001104659-26-029960 000-12957 26765802 34 44841
2026-03-18 8-K FORM 8-K 1.01,3.03,9.01 0001104659-26-029952 000-12957 26765787 34 211881 1 1
2026-03-16 425 425 0001104659-26-028459 000-12957 26756780 34 33398
2026-03-16 8-K FORM 8-K 7.01,9.01 0001104659-26-028449 000-12957 26756667 34 196188 1 1
2026-03-16 SC TO-I/A SC TO-I/A 0001104659-26-028435 005-35587 26756479 34 41644
2026-03-11 8-A12G/A 8-A12G/A 0001104659-26-026175 000-12957 26741654 34 35515
2026-03-11 425 425 0001104659-26-026171 000-12957 26741647 34 56756
2026-03-11 8-K FORM 8-K 1.01,3.03,7.01,9.01 0001104659-26-026169 000-12957 26741641 34 228454 1 1
2026-03-11 SC TO-I/A SC TO-I/A 0001104659-26-026167 005-35587 26741632 34 41638
2026-03-09 425 425 0001104659-26-025226 000-12957 26735092 34 29321
2026-03-09 8-K FORM 8-K 7.01,9.01 0001104659-26-025217 000-12957 26735025 34 193740 1 1
2026-03-09 SC TO-I/A SC TO-I/A 0001104659-26-025204 005-35587 26734913 34 40807
2026-03-03 424B3 424B3 0001104659-26-022903 333-293019 26715037 33 1057287
2026-03-03 SC TO-I/A SC TO-I/A 0001104659-26-022899 005-35587 26714969 34 1059271
2026-03-02 10-K 10-K 0001104659-26-022313 000-12957 26708856 34 4368430 1 1
2026-02-27 8-A12G/A 8-A12G/A 0001104659-26-021059 000-12957 26692913 34 35916
2026-02-27 425 425 0001104659-26-021053 000-12957 26692884 34 57637
2026-02-27 8-K FORM 8-K 1.01,3.03,7.01,9.01 0001104659-26-021051 000-12957 26692872 34 228661 1 1
2026-02-27 SC TO-I/A SC TO-I/A 0001104659-26-021045 005-35587 26692829 34 39415
2026-02-26 SC 14F1 SC 14F1 0001104659-26-020478 005-35587 26687795 34 216675
2026-02-11 SC TO-I/A SC TO-I/A 0001104659-26-013530 005-35587 26622108 34 19749
2026-02-11 425 425 0001104659-26-013514 000-12957 26622033 34 36192
2026-02-11 8-K FORM 8-K 5.07,9.01 0001104659-26-013506 000-12957 26621996 34 198755 1 1
2026-01-30 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000433 333-293019 26585545 33 2059
2026-01-30 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-26-032170 005-35587 26584933 34 11711
2026-01-30 SC TO-I SC TO-I 0001104659-26-008693 005-35587 26584167 34 212808 1 1
2026-01-30 424B3 424B3 0001104659-26-008680 333-293019 26584017 33 10083232
2026-01-30 S-4/A S-4/A 0001104659-26-008573 333-293019 26582879 33 374401
2026-01-30 8-A12G/A 8-A12G/A 0001104659-26-008334 000-12957 26580660 34 30994
2026-01-30 8-K FORM 8-K 1.01,3.03,9.01 0001104659-26-008322 000-12957 26580609 34 208893 1 1
2026-01-28 CORRESP filename1.htm 0001104659-26-007497 8122
2026-01-28 S-4 S-4 0001104659-26-007463 333-293019 26573375 33 26043397 1 1
2025-12-29 UPLOAD filename1.pdf 0000000000-25-011845 377-08849 40814
2025-12-23 8-A12G/A 8-A12G/A 0001104659-25-124262 000-12957 251601390 34 30144
2025-12-23 8-K FORM 8-K 1.01,3.03,9.01 0001104659-25-124254 000-12957 251601317 34 209134 1 1
2025-12-19 DRS filename1.htm 0001104659-25-123300 377-08849 251588625 33 14441479
2025-11-12 10-Q 10-Q 0001104659-25-110410 000-12957 251473141 34 3376903 1 1
2025-10-24 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-25-249981 005-35587 251416357 34 16253
2025-10-24 425 425 0001104659-25-102131 000-12957 251416165 34 156917
2025-10-24 8-K FORM 8-K 1.01,7.01,9.01 0001104659-25-102127 000-12957 251416129 34 348601 1 1
2025-09-30 8-A12G/A 8-A12G/A 0001104659-25-095083 000-12957 251361173 34 29935
2025-09-30 8-K FORM 8-K 1.01,3.03,9.01 0001104659-25-095078 000-12957 251361149 34 210488 1 1
2025-08-14 8-A12G/A 8-A12G/A 0001104659-25-078663 000-12957 251219947 34 30733
2025-08-14 10-Q 10-Q 0001410578-25-001810 000-12957 251218835 34 3222557 1 1
2025-06-23 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-061414 005-35587 251063030 34 19034
2025-06-23 425 425 0001104659-25-061313 000-12957 251062867 34 903142 1 1
2025-06-23 8-K FORM 8-K 1.01,7.01,9.01 0001104659-25-061311 000-12957 251062863 34 1242136 1 1
2025-05-09 10-Q 10-Q 0001410578-25-001164 000-12957 25930355 34 2689274 1 1
2025-04-28 10-K/A 10-K/A 0001104659-25-040183 000-12957 25880263 34 728464 1 1
2025-04-01 8-A12G/A 8-A12G/A 0001104659-25-030601 000-12957 25800341 34 29151
2025-04-01 8-K FORM 8-K 1.01,3.03,9.01 0001104659-25-030585 000-12957 25800227 34 213997 1 1
2025-02-21 10-K 10-K 0001410578-25-000177 000-12957 25651749 34 3910565 1 1
2025-01-10 3 OWNERSHIP DOCUMENT 0001104659-25-002595 3318
2025-01-10 8-K FORM 8-K 5.02,8.01 0001104659-25-002591 000-12957 25523775 34 197977 1 1
2024-12-27 8-K FORM 8-K 8.01 0001104659-24-132163 000-12957 241586039 34 188261 1 1
2024-12-19 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-24-130184 005-35587 241563758 34 21687
2024-11-05 10-Q 10-Q 0001410578-24-001747 000-12957 241427445 34 3339262 1 1
2024-10-01 8-K FORM 8-K 5.07 0001104659-24-104951 000-12957 241343730 34 205366 1 1
2024-08-19 SC 13D/A SC 13D/A 0001104659-24-090923 005-35587 241221999 34 22445
2024-08-08 ARS ARS 0001104659-24-087312 000-12957 241189081 34 9038959
2024-08-08 DEFA14A DEFA14A 0001104659-24-087309 000-12957 241189033 34 957200
2024-08-08 DEF 14A DEF 14A 0001104659-24-087308 000-12957 241189012 34 1239494
2024-08-08 10-Q 10-Q 0001410578-24-001220 000-12957 241188195 34 3242505 1 1
2024-07-29 PRE 14A PRE 14A 0001104659-24-083568 000-12957 241152979 34 3091206
2024-07-11 8-K/A FORM 8-K/A 5.08 0001104659-24-079255 000-12957 241112590 34 190535 1 1
2024-07-02 8-K FORM 8-K 5.08 0001104659-24-077371 000-12957 241096040 34 189125 1 1
2024-06-14 8-K FORM 8-K 8.01 0001104659-24-071747 000-12957 241044704 34 188037 1 1
2024-05-22 8-A12G/A 8-A12G/A 0001104659-24-064260 000-12957 24973349 34 24399
2024-05-22 8-K FORM 8-K 1.01,3.03,9.01 0001104659-24-064247 000-12957 24973239 34 214726 1 1
2024-05-10 10-Q 10-Q 0001410578-24-000735 000-12957 24934884 34 2939922 1 1
2024-04-26 10-K/A FORM 10-K/A 0001104659-24-052919 000-12957 24883613 34 393785 1 1
2024-03-20 10-K 10-K 0001410578-24-000245 000-12957 24767818 34 3798107 1 1
2024-01-05 8-K FORM 8-K 8.01 0001104659-24-001789 000-12957 24516251 34 187512 1 1
2023-11-09 10-Q 10-Q 0001410578-23-002306 000-12957 231393108 34 3149234 1 1
2023-08-07 10-Q 10-Q 0001410578-23-001577 000-12957 231147622 34 3080826 1 1
2023-06-16 4 OWNERSHIP DOCUMENT 0001104659-23-072222 6285
2023-06-14 8-K FORM 8-K 5.07 0001104659-23-071184 000-12957 231014140 34 200711 1 1
2023-05-05 10-Q 10-Q 0001410578-23-000888 000-12957 23893798 34 2794397 1 1
2023-04-20 ARS ARS 0001104659-23-047872 000-12957 23833928 34 319909
2023-04-20 DEFA14A DEFA14A 0001104659-23-047868 000-12957 23833909 34 622534
2023-04-20 DEF 14A DEF 14A 0001104659-23-047865 000-12957 23833897 34 2634436
2023-02-16 10-K 10-K 0001410578-23-000136 000-12957 23638597 34 3754118 1 1
2023-01-06 8-K FORM 8-K 8.01 0001104659-23-001851 000-12957 23515087 34 188774 1 1
2022-11-09 10-Q 10-Q 0001410578-22-003068 000-12957 221372625 34 2971126 1 1
2022-08-04 10-Q 10-Q 0001410578-22-002040 000-12957 221136511 34 2906091 1 1
2022-06-21 3 FORM 3 0001104659-22-072978 3305
2022-06-15 8-K FORM 8-K 5.07 0001104659-22-071455 000-12957 221017951 34 203434 1 1
2022-04-26 10-Q 10-Q 0001410578-22-001018 000-12957 22854320 34 2673912 1 1
2022-04-22 DEFA14A DEFA14A 0001104659-22-048988 000-12957 22845812 34 574432
2022-04-22 DEF 14A DEF 14A 0001104659-22-048979 000-12957 22845739 34 2177694
2022-02-25 10-K 10-K 0001410578-22-000226 000-12957 22680692 34 4001729 1 1
2021-11-05 10-Q FORM 10-Q 0001410578-21-000030 000-12957 211384512 34 2836567 1 1
2021-08-17 4 OWNERSHIP DOCUMENT 0000921895-21-002138 16486
2021-08-05 10-Q FORM 10-Q 0001104659-21-100764 000-12957 211148413 34 2557432 1 1
2021-06-08 8-A12G/A 8-A12G/A 0001104659-21-078224 000-12957 211003375 34 21295
2021-06-08 8-K FORM 8-K 1.01,3.03,5.07,9.01 0001104659-21-078218 001-36435 211002196 34 58756
2021-05-04 10-Q FORM 10-Q 0001104659-21-060966 001-36435 21888435 34 1703126 1
2021-04-14 DEFA14A DEFA14A 0001104659-21-050227 001-36435 21825938 34 426270
2021-04-14 DEF 14A DEF 14A 0001104659-21-050212 001-36435 21825868 34 3511114
2021-04-02 PRE 14A PRE 14A 0001104659-21-046091 001-36435 21802148 34 653836
2021-02-23 10-K FORM 10-K 0001104659-21-026712 001-36435 21665380 34 3351888 1
2021-01-04 8-K FORM 8-K 5.02,9.01 0001104659-21-000308 001-36435 21501878 34 50591
2020-12-21 8-K FORM 8-K 5.07 0001104659-20-138068 001-36435 201404528 34 25299
2020-11-24 424B3 424B3 0001104659-20-129013 333-250031 201344333 33 197029
2020-11-23 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2020-11-23 16:00:00 9999999995-20-003279 333-250031 201339789 33 2018
2020-11-18 4 OWNERSHIP DOCUMENT 0001104659-20-126957 6769
2020-11-18 CORRESP filename1.htm 0001104659-20-126857 12029
2020-11-17 4 OWNERSHIP DOCUMENT 0001104659-20-126458 5311
2020-11-17 UPLOAD filename1.pdf 0000000000-20-011021 40407
2020-11-12 S-1 FORM S-1 0001104659-20-124408 333-250031 201306839 33 370613
2020-11-09 10-Q FORM 10-Q 0001104659-20-123067 001-36435 201297895 34 2922048 1
2020-11-03 DEFA14A DEFA14A 0001104659-20-120990 001-36435 201284058 34 1593631
2020-11-03 DEF 14A DEF 14A 0001104659-20-120989 001-36435 201284046 34 1100414
2020-10-14 4 FORM 4 0001567619-20-017815 13259
2020-10-14 SC 13D/A enzonsc13da10142020.htm 0000928464-20-000065 005-35587 201239506 34 75945
2020-10-14 8-K FORM 8-K 3.02,8.01 0001104659-20-114940 001-36435 201239468 34 22489
2020-09-23 8-K FORM 8-K 3.03,5.03,8.01,9.01 0001104659-20-107817 001-36435 201192250 34 90594
2020-09-23 424B3 424B3 0001104659-20-107616 333-248528 201191049 33 534970
2020-09-21 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2020-09-21 16:00:00 9999999995-20-002518 333-248528 201187788 33 2018
2020-09-17 SC 13D/A AMENDMENT NO. 2 TO THE SCHEDULE 13D 0000921895-20-002429 005-35587 201181337 34 232718
2020-09-17 CORRESP filename1.htm 0001104659-20-106072 12694
2020-09-15 8-K FORM 8-K 8.01,9.01 0001104659-20-105243 001-36435 201176215 34 36661
2020-09-15 S-1/A S-1/A 0001104659-20-105076 333-248528 201174855 33 1093523
2020-09-08 UPLOAD filename1.pdf 0000000000-20-008418 40574
2020-09-02 8-K FORM 8-K 5.08,8.01,9.01 0001104659-20-101872 001-36435 201157164 34 42318
2020-09-01 SC 13D/A enzonsc13da09012020.htm 0000928464-20-000053 005-35587 201154959 34 14834
2020-09-01 8-K FORM 8-K 1.01,9.01 0001104659-20-101397 001-36435 201154618 34 133079
2020-09-01 S-1 FORM S-1 0001104659-20-101387 333-248528 201154582 33 738786
2020-08-31 8-K FORM 8-K 8.01 0001104659-20-100821 001-36435 201152019 34 23366
2020-08-26 4 OWNERSHIP DOCUMENT 0000921895-20-002331 23511
2020-08-18 3 FORM 3 0001104659-20-096633 14032
2020-08-14 8-K FORM 8-K 1.01,3.03,5.03,8.01,9.01 0001104659-20-095642 001-36435 201106504 34 523845
2020-08-14 8-A12G 8-A12G 0001104659-20-095639 000-12957 201106479 34 480116
2020-08-14 3 FORM 3 0001104659-20-095224 13169
2020-08-07 SC 13D/A enzonsc13da08072020.htm 0000928464-20-000032 005-35587 201086835 34 10910
2020-08-07 8-K FORM 8-K 5.02 0001104659-20-092029 001-36435 201085616 34 23035
2020-08-06 4 OWNERSHIP DOCUMENT 0000921895-20-002115 21793
2020-08-06 3 OWNERSHIP DOCUMENT 0000921895-20-002114 20931
2020-08-05 SC 13D/A AMENDMENT NO. 1 TO THE SCHEDULE 13D 0000921895-20-002102 005-35587 201078383 34 278563
2020-07-29 10-Q FORM 10-Q 0001104659-20-087796 001-36435 201057384 34 1568925 1
2020-04-30 10-Q FORM 10-Q 0001104659-20-054427 001-36435 20835688 34 1419822 1
2020-04-24 10-K/A FORM 10-K/A 0001104659-20-050989 001-36435 20815013 34 212507
2020-04-16 SC 13D THE SCHEDULE 13D 0000921895-20-001119 005-35587 20796985 34 167574
2020-03-31 4/A OWNERSHIP DOCUMENT 0000921895-20-000958 19033
2020-03-31 3 OWNERSHIP DOCUMENT 0000921895-20-000957 4865
2020-03-27 4 xslF345X03/e619511_4-enzn.xml 0001193805-20-000418 16895
2020-03-27 SC 13G/A AMENDMENT NO. 3 TO THE SCHEDULE 13G 0000921895-20-000931 005-35587 20753064 34 145294
2020-02-19 10-K FORM 10-K 0001104659-20-022802 001-36435 20629673 34 2716545 1
2020-01-22 SC 13G/A SC 13G/A 0001104659-20-005975 005-35587 20539528 34 105024
2020-01-16 SC 13G/A SC 13G/A 0001062993-20-000184 005-35587 20529446 34 30587
2019-11-06 10-Q FORM 10-Q 0001104659-19-060500 001-36435 191196313 34 1604763 1
2019-08-22 8-K 8-K 5.07,8.01 0001104659-19-046989 001-36435 191046698 34 47001
2019-08-07 10-Q FORM 10-Q 0001144204-19-038191 001-36435 191005470 34 1567916 1
2019-07-12 DEFA14A DEFA14A 0001140361-19-012844 001-36435 19952077 34 413443
2019-07-12 DEF 14A DEF 14A 0001140361-19-012843 001-36435 19952076 34 683692
2019-05-08 10-Q FORM 10-Q 0001144204-19-024510 001-36435 19806799 34 1518855 1
2019-04-25 10-K/A 10-K/A 0001144204-19-021264 001-36435 19767634 34 187088
2019-02-21 10-K FORM 10-K 0001144204-19-009301 001-36435 19621902 34 3664184 1
2019-02-14 4 OWNERSHIP DOCUMENT 0000921895-19-000500 18484
2019-02-14 SC 13G/A AMENDMENT NO. 2 TO THE SCHEDULE 13G 0000921895-19-000426 005-35587 19604076 34 111383
2019-02-01 8-K FORM 8-K 8.01 0001144204-19-004157 001-36435 19557123 34 18343
2019-01-31 SC 13G/A SC 13G/A 0001144204-19-004131 005-35587 19556664 34 91862
2019-01-09 4 OWNERSHIP DOCUMENT 0000921895-19-000048 41629
2019-01-09 4 OWNERSHIP DOCUMENT 0000921895-19-000047 55421
2019-01-03 SC 13G/A SC 13G/A 0001062993-19-000013 005-35587 19504271 34 26853
2018-11-07 10-Q 10-Q 0001144204-18-057974 001-36435 181166505 34 1835843 1
2018-08-13 8-K FORM 8-K 5.07 0001144204-18-043721 001-36435 181010260 34 25257
2018-08-10 10-Q FORM 10-Q 0001144204-18-043614 001-36435 181009038 34 1981896 1
2018-06-29 DEFA14A DEFA14A 0001144204-18-036477 001-36435 18927277 34 365248
2018-06-29 DEF 14A DEFINITIVE PROXY STATEMENT 0001144204-18-036475 001-36435 18927276 34 505075
2018-05-10 10-Q FORM 10-Q 0001144204-18-027186 001-36435 18823848 34 1403678 1
2018-04-25 10-K/A 10-K/A 0001144204-18-022403 001-36435 18774746 34 218506
2018-04-13 3 OWNERSHIP DOCUMENT 0000921895-18-001310 10382
2018-04-13 SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0000921895-18-001302 005-35587 18754120 34 116123
2018-03-21 10-K 10-K 0001144204-18-016199 001-36435 18705091 34 2991534 1
2018-02-13 15-12G 15-12G 0001144204-18-007983 000-12957 18603970 34 12219
2018-02-09 SC 13G SCHEDULE 13G 0001144204-18-007007 005-35587 18592887 34 88983
2018-01-22 SC 13G SC 13G 0001062993-18-000271 005-35587 18540519 34 26795
2017-11-09 10-Q FORM 10-Q 0001144204-17-057832 001-36435 171191888 34 1435345 1
2017-08-10 8-K FORM 8-K 8.01 0001144204-17-042087 001-36435 171021981 34 16128
2017-08-10 10-Q FORM 10-Q 0001144204-17-042058 001-36435 171021654 34 1419195 1
2017-06-30 8-K FORM 8-K 5.07,8.01 0001144204-17-035053 001-36435 17940284 34 35475
2017-05-24 SC 13G THE SCHEDULE 13G 0000921895-17-001629 005-35587 17867110 34 58873
2017-05-12 DEFA14A DEFA14A 0001144204-17-026614 001-36435 17836385 34 934348
2017-05-12 DEF 14A DEF 14A 0001144204-17-026613 001-36435 17836381 34 924916
2017-05-11 10-Q FORM 10-Q 0001144204-17-026492 001-36435 17835005 34 1386101 1
2017-04-28 10-K/A FORM 10-K/A 0001144204-17-022820 001-36435 17791535 34 179700
2017-03-24 10-K 10-K 0001144204-17-016511 001-36435 17712877 34 3261061 1
2017-02-14 SC 13G/A 13G/A 0001037389-17-000072 005-35587 17603240 34 13533
2016-12-08 SC 13D/A enznsch13damd10120816.htm 0000928464-16-000248 005-35587 162042062 34 14756
2016-12-08 8-K FORM 8-K 8.01 0001144204-16-138574 001-36435 162041585 34 18542
2016-11-29 4 FORM 4 0001140361-16-088016 12663
2016-11-29 SC 13D/A enznsch13damd9112816.htm 0000928464-16-000246 005-35587 162021248 34 122786
2016-11-14 8-K FORM 8-K 8.01 0001144204-16-134444 001-36435 161996918 34 14359
2016-11-10 10-Q FORM 10-Q 0001144204-16-133295 001-36435 161988242 34 1468017 1
2016-10-26 8-K FORM 8-K 8.01 0001144204-16-129621 001-36435 161952929 34 11927
2016-08-10 10-Q 10-Q 0001144204-16-118076 001-36435 161822158 34 1399998 1
2016-08-09 8-K FORM 8-K 8.01 0001144204-16-117736 001-36435 161818434 34 13553
2016-07-05 8-K FORM 8-K 5.07,8.01 0001144204-16-111331 001-36435 161748125 34 30452
2016-06-10 25-NSE xslF25X02/primary_doc.xml 0001354457-16-000401 000-12957 34 3767 1
2016-06-09 SC 13G/A enzon.pharmaceutic.txt 0000215457-16-006294 005-35587 161705605 34 12372
2016-05-16 8-K FORM 8-K 3.01 0001144204-16-102656 001-36435 161654360 34 16394
2016-05-13 DEFA14A DEFA14A 0001144204-16-101408 001-36435 161645781 34 578843
2016-05-13 DEF 14A DEF 14A 0001144204-16-101406 001-36435 161645774 34 863317
2016-05-09 10-Q 10-Q 0001144204-16-099969 001-36435 161632492 34 1314763 1
2016-04-28 10-K/A FORM 10-K/A 0001144204-16-097169 001-36435 161600909 34 184504
2016-04-05 3 OWNERSHIP DOCUMENT 0001144204-16-092800 4890
2016-03-21 10-K FORM 10-K 0001144204-16-089172 001-36435 161518891 34 3739219 1
2016-03-21 8-K FORM 8-K 5.02,8.01 0001144204-16-089169 001-36435 161518847 34 19235
2016-02-23 8-K FORM 8-K 8.01 0001144204-16-083875 001-36435 161449043 34 17660
2016-02-12 SC 13G/A enzon13ga2.htm 0000935836-16-000729 005-35587 161417240 34 46640
2016-02-12 SC 13G ENZON PHARMACEUTICALS, INC. 0001037389-16-000156 005-35587 161413072 34 13598
2016-02-09 8-K FORM 8-K 1.01,8.01,9.01 0001144204-16-080081 001-36435 161401108 34 51698
2016-02-09 DEFA14A FORM 8-K 0001144204-16-080082 001-36435 161401087 34 51556
2016-01-26 SC 13G/A enzon.pharmaceutic.2015.txt 0000215457-16-002745 005-35587 161360975 34 13273
2015-12-07 8-K FORM 8-K 8.01 0001144204-15-069647 001-36435 151272836 34 11300
2015-12-03 8-K 8-K 8.01 0001144204-15-069086 001-36435 151266184 34 11879
2015-11-12 8-K CURRENT REPORT 3.01 0001144204-15-064280 001-36435 151220983 34 14889
2015-11-06 10-Q FORM 10-Q 0001144204-15-063360 001-36435 151209986 34 1666996 1
2015-09-15 8-K 8-K 1.01 0001144204-15-055075 001-36435 151108343 34 14904
2015-08-07 10-Q 10-Q 0001144204-15-047327 001-36435 151037598 34 1709518 1
2015-07-08 8-K FORM 8-K 8.01 0001144204-15-041474 001-36435 15977755 34 14335
2015-07-02 8-K FORM 8-K 5.07,8.01 0001144204-15-040856 001-36435 15969977 34 29894
2015-05-19 ARS AUTO-GENERATED PAPER DOCUMENT 9999999997-15-010062 001-36435 15007475 34 1684
2015-05-15 DEFA14A DEFA14A 0001144204-15-031663 001-36435 15870064 34 33466
2015-05-15 DEF 14A DEF 14A 0001144204-15-031658 001-36435 15870024 34 862886
2015-05-13 10-Q FORM 10-Q 0001144204-15-029931 001-36435 15856608 34 1910731 1
2015-04-28 PRE 14A FORM PRE 14A 0001144204-15-025623 001-36435 15799648 34 862956
2015-04-24 10-K/A FORM 10-K/A 0001144204-15-025025 001-36435 15792616 34 203539
2015-03-05 10-K 10-K 0001144204-15-014238 001-36435 15677594 34 6061650 1
2015-02-06 SC 13G/A enzon13ga.htm 0000935836-15-000091 005-35587 15581348 34 45329
2015-01-22 SC 13G/A enzon.pharmaceuticals.i.txt 0001086364-15-000471 005-35587 15541385 34 13193
2014-12-10 8-K 8-K 8.01 0001144204-14-073174 001-36435 141278300 34 14618
2014-12-05 8-K FORM 8-K 8.01 0001144204-14-072592 001-36435 141269917 34 14083
2014-11-28 4 FORM 4 0001140361-14-043674 29406
2014-11-06 10-Q 10-Q 0001144204-14-065728 001-36435 141201538 34 2686009 1
2014-08-08 10-Q 10-Q 0001144204-14-048065 001-36435 141027528 34 2618868 1
2014-07-16 8-K CURRENT REPORT 8.01 0001144204-14-043230 001-36435 14976804 34 14379
2014-06-12 8-K FORM 8-K 3.01 0001144204-14-037136 001-36435 14905968 34 16227
2014-05-30 8-K 8-K 5.07,8.01 0001144204-14-034657 001-36435 14880743 34 24647
2014-05-19 8-K 8-K 8.01 0001144204-14-032110 001-36435 14855156 34 14980
2014-05-19 DEFA14A 8-K 0001144204-14-032112 001-36435 14855139 34 14953
2014-05-09 8-K 8-K 3.01 0001144204-14-029085 001-36435 14829612 34 13225
2014-05-09 10-Q 10-Q 0001144204-14-029062 001-36435 14829115 34 2385649 1
2014-05-01 8-A12B 8-A12B 0001144204-14-026849 001-36435 14805240 34 31493
2014-05-01 8-K FORM 8-K 1.01,3.03,5.03,8.01,9.01 0001144204-14-026841 000-12957 14805127 34 460825
2014-04-18 ARS AUTO-GENERATED PAPER DOCUMENT 9999999997-14-009150 001-36435 14006744 34 1684
2014-04-16 DEFA14A DEFA14A 0001144204-14-022909 000-12957 14766535 34 605907
2014-04-16 DEF 14A DEF 14A 0001144204-14-022906 000-12957 14766534 34 656864
2014-04-09 SC 13G/A ENZN13GAMEND6 0001061768-14-000026 005-35587 14753897 34 132747
2014-03-25 8-K 8-K 3.01 0001144204-14-017632 000-12957 14716310 34 16076
2014-03-14 10-K 10-K 0001144204-14-015753 000-12957 14694708 34 10188622 1
2014-03-13 SC 13G SC 13G 0001193125-14-096618 005-35587 14689566 34 82455
2014-02-12 SC 13G/A enzonpharmaceuticalsinc.htm 0000932471-14-003866 005-35587 14597003 34 52117
2014-01-10 SC 13G/A enzon.pharmaceuticals.inc..txt 0001086364-14-000047 005-35587 14519653 34 13270
2014-01-09 SC 13G/A ENZN13GAMEND5.PDML 0001061768-14-000004 005-35587 14518911 34 159646
2013-12-16 8-K CURRENT REPORT 5.02,8.01 0001144204-13-067350 000-12957 131277944 34 21481
2013-12-13 3 OWNERSHIP DOCUMENT 0001144204-13-067286 3149
2013-12-05 8-K 8-K 8.01 0001144204-13-065845 000-12957 131260205 34 11714
2013-11-21 8-K 8-K 5.07,8.01 0001144204-13-063553 000-12957 131235950 34 26599
2013-11-12 10-Q FORM 10-Q 0001144204-13-060539 000-12957 131210594 34 4663958 1
2013-10-22 8-K 8-K 5.02,8.01 0001144204-13-056282 000-12957 131163914 34 17739
2013-10-15 ARS AUTO-GENERATED PAPER DOCUMENT 9999999997-13-015893 000-12957 13003521 34 1684
2013-10-15 8-K 8-K 8.01 0001144204-13-055265 000-12957 131152345 34 13199
2013-10-11 DEFA14A DEFA14A 0001144204-13-054854 000-12957 131147004 34 604270
2013-10-11 DEF 14A DEF 14A 0001144204-13-054852 000-12957 131147001 34 1078891
2013-10-09 3 FORM 3 0001140361-13-038299 3387
2013-10-09 SC 13D/A enznsch13damd8100913.htm 0000928464-13-000257 005-35587 131143675 34 35355
2013-10-09 8-K 8-K 5.02 0001144204-13-054571 000-12957 131143667 34 20204
2013-10-07 3 OWNERSHIP DOCUMENT 0001144204-13-054317 3296
2013-10-07 3 OWNERSHIP DOCUMENT 0001144204-13-054315 3262
2013-10-01 8-K 8-K 1.01,5.02,8.01 0001144204-13-053370 000-12957 131127299 34 27107
2013-09-19 4 OWNERSHIP DOCUMENT 0001144204-13-051642 7326
2013-08-12 8-K 8-K 4.01,9.01 0001144204-13-044762 000-12957 131030327 34 28197
2013-08-09 8-K 8-K 5.02 0001144204-13-044471 000-12957 131027189 34 16238
2013-08-06 10-Q 10-Q 0001144204-13-043344 000-12957 131014299 34 5263669 1
2013-07-25 8-K 8-K 5.02 0001144204-13-041192 000-12957 13986828 34 17962
2013-06-14 SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0001193125-13-259858 005-35587 13915140 34 88949
2013-05-10 10-Q FORM 10-Q 0001144204-13-027985 000-12957 13834028 34 2784762 1
2013-05-06 8-K 8-K 8.01 0001144204-13-026576 000-12957 13817035 34 16912
2013-04-30 10-K/A FORM 10-K/A 0001144204-13-025224 000-12957 13798602 34 600414
2013-04-24 8-K 8-K 8.01,9.01 0001144204-13-023447 000-12957 13777313 34 33044
2013-03-26 8-K FORM 8-K 2.05 0001144204-13-017546 000-12957 13717162 34 13536
2013-03-18 8-K FORM 8-K 2.02,9.01 0001144204-13-015913 000-12957 13698867 34 119809
2013-03-18 10-K 10-K 0001144204-13-015878 000-12957 13698341 34 7237532 1
2013-02-28 8-K 8-K 5.02,9.01 0001144204-13-012084 000-12957 13652857 34 64053
2013-02-21 8-K 8-K 8.01 0001144204-13-010540 000-12957 13631258 34 14110
2013-02-13 SC 13G/A ENZN13GAMEND4 0001061768-13-000014 005-35587 13603513 34 157726
2013-02-12 8-K 8-K 5.02,5.03,9.01 0001144204-13-007817 000-12957 13597665 34 91441
2013-02-12 SC 13G enzonphamaceuticalsinc.htm 0000932471-13-004167 005-35587 13597024 34 52085
2013-02-11 SC 13G/A enzon.pharmaceuticals.inc..txt 0001086364-13-003548 005-35587 13588464 34 13419
2013-02-06 SC 13G/A enzon.pharmaceuticals.inc..txt 0001086364-13-002727 005-35587 13576404 34 13442
2013-01-31 SC 13G/A enzon13ga3123112.htm 0001033427-13-000012 005-35587 13560978 34 94945
2013-01-25 4 OWNERSHIP DOCUMENT 0001144204-13-004109 6316
2013-01-25 4 OWNERSHIP DOCUMENT 0001144204-13-004105 6221
2013-01-25 4 OWNERSHIP DOCUMENT 0001144204-13-004103 6229
2013-01-04 4 OWNERSHIP DOCUMENT 0001144204-13-000678 5888
2013-01-04 4 OWNERSHIP DOCUMENT 0001144204-13-000676 5887
2013-01-04 4 OWNERSHIP DOCUMENT 0001144204-13-000673 5750
2013-01-04 4 OWNERSHIP DOCUMENT 0001144204-13-000671 5890
2013-01-04 4 OWNERSHIP DOCUMENT 0001144204-13-000668 5858
2013-01-04 4 OWNERSHIP DOCUMENT 0001144204-13-000666 5990
2013-01-02 SC 13G SCHEDULE 13G - ENZON PHARMACEUTICALS, INC. 0000906344-13-000004 005-35587 13502464 34 118730
2012-12-20 8-K 8-K 2.05,8.01,9.01 0001144204-12-069009 000-12957 121277976 34 46526
2012-11-30 8-K 8-K 8.01,9.01 0001144204-12-065661 000-12957 121233178 34 24885
2012-11-28 SC 13D/A enznsch13damd7112712.htm 0000928464-12-000301 005-35587 121227687 34 35324
2012-11-13 SC 13D/A enznsch13damd6110912.htm 0000928464-12-000282 005-35587 121195074 34 183766
2012-11-09 10-Q FORM 10-Q 0001144204-12-060778 000-12957 121193061 34 3563794 1
2012-11-08 4 OWNERSHIP DOCUMENT 0001144204-12-060400 8409
2012-10-31 8-K 8-K 2.02,9.01 0001144204-12-058564 000-12957 121169977 34 80750
2012-10-12 UPLOAD filename1.pdf 0000000000-12-056588 34692
2012-09-20 CORRESP filename1.htm 0001144204-12-052206 40736
2012-09-07 UPLOAD filename1.pdf 0000000000-12-048852 141944
2012-09-06 SC 13G/A enzn13ga2083112.htm 0001033427-12-000032 005-35587 121076087 34 97534
2012-08-21 10-Q/A 10-Q/A 0001144204-12-047370 000-12957 121047540 34 2309032 1
2012-08-15 4 OWNERSHIP DOCUMENT 0001144204-12-046171 4789
2012-08-13 CORRESP filename1.htm 0001144204-12-044890 79016
2012-08-13 4 OWNERSHIP DOCUMENT 0001144204-12-044710 4796
2012-08-03 10-Q FORM 10-Q 0001144204-12-042768 000-12957 121006669 34 364746
2012-08-01 8-K 8-K 2.02,9.01 0001144204-12-042169 000-12957 12998602 34 71755
2012-07-30 UPLOAD filename1.pdf 0000000000-12-040592 166264
2012-07-03 4 OWNERSHIP DOCUMENT 0001144204-12-038081 5470
2012-07-03 4 OWNERSHIP DOCUMENT 0001144204-12-038077 5332
2012-07-03 4 OWNERSHIP DOCUMENT 0001144204-12-038074 5441
2012-07-03 4 OWNERSHIP DOCUMENT 0001144204-12-038070 5469
2012-07-03 4 OWNERSHIP DOCUMENT 0001144204-12-038067 5472
2012-07-03 4 OWNERSHIP DOCUMENT 0001144204-12-038064 5572
2012-06-26 8-K/A c70100_8ka.htm 5.02 0000930413-12-003733 000-12957 12927940 34 10223
2012-06-21 4 OWNERSHIP DOCUMENT 0000930413-12-003658 11523
2012-06-06 4 OWNERSHIP DOCUMENT 0000930413-12-003456 4856
2012-06-06 4 OWNERSHIP DOCUMENT 0000930413-12-003455 5359
2012-05-22 8-K c69791_8k.htm 5.02,5.07 0000930413-12-003232 000-12957 12862296 34 25250
2012-05-07 8-K c69620_8k.htm 8.01,9.01 0000930413-12-002864 000-12957 12816841 34 34280
2012-05-02 10-Q c69479_10-q.htm 0000930413-12-002742 000-12957 12805489 34 1981517 1
2012-05-02 8-K c69509_8-k.htm 2.02,9.01 0000930413-12-002722 000-12957 12803150 34 81962
2012-04-10 SC 13G/A ENZON PHARMACEUTICALS SC 13GA 3-31-2012 0001140361-12-019887 005-35587 12751546 34 22998
2012-04-06 ARS AUTO-GENERATED PAPER DOCUMENT 9999999997-12-008585 000-12957 12026676 34 1684
2012-04-06 DEFA14A c69170_defa14a.htm 0000930413-12-002094 000-12957 12747023 34 25265
2012-04-06 DEF 14A c68795_def14a.htm 0000930413-12-002093 000-12957 12747011 34 652719
2012-03-29 4 OWNERSHIP DOCUMENT 0000930413-12-001901 5556
2012-03-16 4 OWNERSHIP DOCUMENT 0000930413-12-001600 5322
2012-03-12 10-K c68781_10-k.htm 0000930413-12-001483 000-12957 12683808 34 5286158 1
2012-03-12 8-K c68804_8-k.htm 2.02,9.01 0000930413-12-001477 000-12957 12682517 34 121942
2012-02-29 4 FORM 4 0001140361-12-011943 8271
2012-02-29 3 FORM 3 0001140361-12-011941 3371
2012-02-28 8-K c68733_8k.htm 5.02 0000930413-12-001168 000-12957 12648777 34 11520
2012-02-28 3/A FORM 3/A 0001140361-12-011502 10554
2012-02-28 SC 13D/A enznsch13damd5022412.txt 0000928475-12-000028 005-35587 12648380 34 27005
2012-02-14 SC 13G/A ENZON PHARMACEUTICALS SC 13GA 12-31-2011 0001140361-12-007948 005-35587 12607888 34 23235
2012-02-14 SC 13G/A ENZON PHARMACEUTICALS, INC. 0000902664-12-000344 005-35587 12604343 34 113842
2012-02-13 8-K c68568_8-k.htm 8.01 0000930413-12-000690 000-12957 12595509 34 9552
2012-02-10 SC 13G/A ENZN13GAMEND3 0001061768-12-000014 005-35587 12592789 34 160642
2012-02-09 SC 13G/A enzon.pharmaceuticals.inc..txt 0001086364-12-000355 005-35587 12584388 34 13431
2012-02-06 SC 13G/A enzon13ga1123111.htm 0001033427-12-000010 005-35587 12572182 34 96966
2012-01-19 4/A OWNERSHIP DOCUMENT 0000930413-12-000231 6665
2012-01-19 4 OWNERSHIP DOCUMENT 0000930413-12-000230 8323
2012-01-19 4 OWNERSHIP DOCUMENT 0000930413-12-000229 9233
2012-01-19 4 OWNERSHIP DOCUMENT 0000930413-12-000228 8427
2012-01-19 4 OWNERSHIP DOCUMENT 0000930413-12-000227 8325
2012-01-19 4 OWNERSHIP DOCUMENT 0000930413-12-000226 7720
2012-01-05 4 OWNERSHIP DOCUMENT 0000930413-12-000048 5889

Latest XBRL company facts

One latest value per concept from companyfacts (443 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 14.33M 2026-11-01 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
dei EntityPublicFloat Entity Public Float USD 4.92M 2025-06-30 2025 FY 10-K/A 2026-04-29 0001104659-26-051643
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 42.95M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap AccountsReceivableGrossCurrent Accounts Receivable, before Allowance for Credit Loss, Current USD 73.00M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 69.98M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 2.35M 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-09 0001144204-12-060778
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 0 2016-12-31 2016 FY 10-K 2017-03-24 0001144204-17-016511
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 27.89M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 33,000 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap AccruedRentCurrent Accrued Rent, Current USD 0 2015-12-31 2015 FY 10-K 2016-03-21 0001144204-16-089172
us-gaap AccruedRentNoncurrent Accrued Rent, Noncurrent USD 0 2015-12-31 2015 FY 10-K 2016-03-21 0001144204-16-089172
us-gaap AccruedRoyaltiesCurrent Accrued Royalties, Current USD 29,000 2021-12-31 2021 FY 10-K 2022-02-25 0001410578-22-000226
us-gaap AccruedRoyaltiesCurrentAndNoncurrent Accrued Royalties USD 324,000 2019-12-31 2020 Q3 10-Q 2020-11-09 0001104659-20-123067
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 347.82M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -59.09M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 267.92M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings USD 2.12M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities USD -8.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-21 0001410578-25-000177
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 3.02M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 1.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 1.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 25,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-02-16 0001410578-23-000136
us-gaap AreaOfLand Area of Land acre 30,000 2015-12-31 2015 FY 10-K 2016-03-21 0001144204-16-089172
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 362,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap Assets Assets USD 427.47M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap AssetsCurrent Assets, Current USD 226.32M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap AssetsHeldForSaleCurrent Assets Held-for-sale, Current (Deprecated 2014-01-31) USD 55,000 2014-03-31 2014 Q1 10-Q 2014-05-09 0001144204-14-029062
us-gaap AssetsHeldForSalePropertyPlantAndEquipment Assets Held-for-sale, Property, Plant and Equipment (Deprecated 2014-01-31) USD 90,000 2013-12-31 2013 FY 10-K 2014-03-14 0001144204-14-015753
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Assets, Current USD 0 2014-12-31 2014 FY 10-K 2015-03-05 0001144204-15-014238
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 119.39M 2012-12-31 2013 FY 10-K 2014-03-14 0001144204-14-015753
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 119.31M 2012-12-31 2013 FY 10-K 2014-03-14 0001144204-14-015753
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value USD 38.10M 2012-12-31 2013 FY 10-K 2014-03-14 0001144204-14-015753
us-gaap AvailableForSaleSecuritiesCurrent Available-for-sale Securities, Current USD 25.25M 2011-09-30 2011 Q3 10-Q 2011-11-04 0000930413-11-006994
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31) USD 119.31M 2013-12-31 2013 FY 10-K 2014-03-14 0001144204-14-015753
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One USD 119.31M 2013-12-31 2013 FY 10-K 2014-03-14 0001144204-14-015753
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 119.39M 2013-12-31 2013 FY 10-K 2014-03-14 0001144204-14-015753
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value USD 119.39M 2013-12-31 2013 FY 10-K 2014-03-14 0001144204-14-015753
us-gaap AvailableForSaleSecuritiesFairValueDisclosure Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) USD 77.57M 2013-03-31 2013 Q1 10-Q 2013-05-10 0001144204-13-027985
us-gaap AvailableForSaleSecuritiesGrossRealizedGainsLossesSaleProceeds Available-for-sale Securities, Gross Realized Gains (Losses), Sale Proceeds (Deprecated 2018-01-31) USD 300,000 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-05 0001144204-15-014238
us-gaap AvailableforsaleSecuritiesGrossUnrealizedGain Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) USD 55,000 2013-03-31 2013 Q1 10-Q 2013-05-10 0001144204-13-027985
us-gaap AvailableForSaleSecuritiesGrossUnrealizedGains Available-for-sale Securities, Gross Unrealized Gain USD 94,000 2012-01-01 2012-12-31 2013 FY 10-K 2014-03-14 0001144204-14-015753
us-gaap AvailableForSaleSecuritiesGrossUnrealizedLoss Available-for-sale Securities, Gross Unrealized Loss USD 11,000 2012-01-01 2012-12-31 2013 FY 10-K 2014-03-14 0001144204-14-015753
us-gaap AvailableForSaleSecuritiesGrossUnrealizedLosses1 Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) USD 16,000 2013-03-31 2013 Q1 10-Q 2013-05-10 0001144204-13-027985
us-gaap BasicEarningsPerShareProForma Basic Earnings Per Share, Pro Forma USD/shares -7.46 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap BusinessAcquisitionCostOfAcquiredEntityCashPaid Business Acquisition, Cost of Acquired Entity, Cash Paid (Deprecated 2013-01-31) USD 308.00M 2010-06-30 2012 FY 10-K 2013-03-18 0001144204-13-015878
us-gaap BusinessAcquisitionCostOfAcquiredEntityPurchasePrice Business Acquisition, Cost of Acquired Entity, Purchase Price (Deprecated 2013-01-31) USD 303.00M 2010-06-30 2012 FY 10-K 2013-03-18 0001144204-13-015878
us-gaap BusinessAcquisitionCostOfAcquiredEntityTransactionCosts Business Acquisition, Transaction Costs USD 5.00M 2010-06-30 2012 FY 10-K 2013-03-18 0001144204-13-015878
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 7.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap Cash Cash USD 38.99M 2015-06-30 2015 Q2 10-Q 2015-08-07 0001144204-15-047327
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 7.75M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -2.94M 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-08 0001144204-19-024510
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 7.75M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -1.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 42.40M 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations Cash Provided by (Used in) Investing Activities, Discontinued Operations USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-18 0001144204-13-015878
us-gaap CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations Cash Provided by (Used in) Operating Activities, Discontinued Operations USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-18 0001144204-13-015878
us-gaap CommitmentsAndContingencies Commitments and Contingencies USD 0 2020-09-30 2020 Q3 10-Q 2020-11-09 0001104659-20-123067
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 25.53M 2012-12-31 2012 FY 10-K 2013-03-18 0001144204-13-015878
us-gaap CommonStockDividendsPerShareCashPaid Common Stock, Dividends, Per Share, Cash Paid USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap CommonStockDividendsPerShareDeclared Common Stock, Dividends, Per Share, Declared USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 170.00M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 14.33M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 14.33M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap CommonStockValue Common Stock, Value, Issued USD 143,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -21.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -22.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap CostOfRevenue Cost of Revenue USD 243.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 55,000 2013-07-01 2013-09-30 2014 Q3 10-Q 2014-11-06 0001144204-14-065728
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 2,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 2,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 147.821 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-18 0001144204-13-015878
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 6.76 2013-03-31 2013 Q1 10-Q 2013-05-10 0001144204-13-027985
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.04 2012-12-31 2013 FY 10-K 2014-03-14 0001144204-14-015753
us-gaap DebtInstrumentRepurchasedFaceAmount Debt Instrument, Repurchased Face Amount USD 13.65M 2012-09-30 2012 Q3 10-Q 2012-11-09 0001144204-12-060778
us-gaap DeferredCompensationLiabilityCurrent Deferred Compensation Liability, Current USD 0 2012-12-31 2012 FY 10-K 2013-03-18 0001144204-13-015878
us-gaap DeferredCompensationPlanAssets Deferred Compensation Plan Assets USD 2.50M 2011-12-31 2012 FY 10-K 2013-03-18 0001144204-13-015878
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 13,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap DeferredFederalStateAndLocalTaxExpenseBenefit Deferred Federal, State and Local, Tax Expense (Benefit) USD 17,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap DeferredFinanceCostsCurrentNet Debt Issuance Costs, Current, Net USD 1.61M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap DeferredFinanceCostsNoncurrentNet Debt Issuance Costs, Noncurrent, Net USD 1.95M 2026-06-30 2026 Q2 10-Q 2026-08-03 0001104659-26-089804
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 17,000 2024-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 119,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 457,000 2020-09-30 2020 Q3 10-Q 2020-11-09 0001104659-20-123067
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 4,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap DeferredTaxAssetsCapitalLossCarryforwards Deferred Tax Assets, Capital Loss Carryforwards USD 0 2018-12-31 2018 FY 10-K 2019-02-21 0001144204-19-009301
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 29.71M 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 0 2013-12-31 2013 FY 10-K 2014-03-14 0001144204-14-015753
us-gaap DeferredTaxAssetsInvestments Deferred Tax Assets, Investments USD 0 2014-12-31 2014 FY 10-K 2015-03-05 0001144204-15-014238
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 17,000 2024-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap DeferredTaxAssetsLiabilitiesNetCurrent Deferred Tax Assets, Net, Current USD 2.20M 2017-09-30 2017 Q3 10-Q 2017-11-09 0001144204-17-057832
us-gaap DeferredTaxAssetsLiabilitiesNetNoncurrent Deferred Tax Assets, Net, Noncurrent USD 0 2017-12-31 2017 FY 10-K 2018-03-21 0001144204-18-016199
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2013-12-31 2013 FY 10-K 2014-03-14 0001144204-14-015753
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 20.91M 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 0 2016-12-31 2016 FY 10-K 2017-03-24 0001144204-17-016511
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax Deferred Tax Assets, Tax Credit Carryforwards, Alternative Minimum Tax USD 0 2017-12-31 2017 FY 10-K 2018-03-21 0001144204-18-016199
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 8.80M 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap DeferredTaxAssetsTaxDeferredExpense Deferred Tax Assets, Tax Deferred Expense USD 0 2022-09-30 2022 Q3 10-Q 2022-11-09 0001410578-22-003068
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation USD 0 2016-12-31 2016 FY 10-K 2017-03-24 0001144204-17-016511
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 0 2016-12-31 2016 FY 10-K 2017-03-24 0001144204-17-016511
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 29.71M 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 0 2013-12-31 2013 FY 10-K 2014-03-14 0001144204-14-015753
us-gaap DeferredTaxLiabilitiesTaxDeferredIncome Deferred Tax Liabilities, Tax Deferred Income USD 800,000 2011-12-31 2012 FY 10-K 2013-03-18 0001144204-13-015878
us-gaap DeferredTaxLiabilitiesUndistributedForeignEarnings Deferred Tax Liabilities, Undistributed Foreign Earnings USD 0 2012-12-31 2012 FY 10-K 2013-03-18 0001144204-13-015878
us-gaap DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities Deferred Tax Liabilities, Unrealized Gains on Trading Securities USD 0 2013-12-31 2013 FY 10-K 2014-03-14 0001144204-14-015753
us-gaap DefinedBenefitPlanContributionsByEmployer Defined Benefit Plan, Plan Assets, Contributions by Employer USD 787,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 742,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-05 0001144204-15-014238
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.06 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-05 0001144204-15-014238
us-gaap DefinedContributionPlanMaximumAnnualContributionPerEmployeePercent Defined Contribution Plan, Maximum Annual Contribution Per Employee, Percent (Deprecated 2013-01-31) pure 0.5 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-18 0001144204-13-015878
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 0.5 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-05 0001144204-15-014238
us-gaap Depreciation Depreciation USD 11.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-05 0001144204-15-014238
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 12.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap DilutedEarningsPerShareProForma Diluted Earnings Per Share Pro Forma USD/shares -7.46 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax USD 3.62M 2010-01-01 2010-01-29 2012 FY 10-K 2013-03-18 0001144204-13-015878
us-gaap DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax USD 176.40M 2010-04-01 2010-06-30 2012 FY 10-K 2013-03-18 0001144204-13-015878
us-gaap DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation Discontinued Operation, Tax Effect of Gain (Loss) from Disposal of Discontinued Operation USD 0 2010-01-01 2010-01-29 2012 FY 10-K 2013-03-18 0001144204-13-015878
us-gaap DisposalGroupIncludingDiscontinuedOperationRevenue Disposal Group, Including Discontinued Operation, Revenue USD 8.72M 2010-01-01 2010-01-29 2012 FY 10-K 2013-03-18 0001144204-13-015878
us-gaap DividendsCommonStock Dividends, Common Stock USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap DividendsCommonStockCash Dividends, Common Stock, Cash USD 5.31M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-06 0001104659-19-060500
us-gaap DividendsCommonStockStock Dividends, Common Stock, Stock USD 1.27M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-20 0001410578-24-000245
us-gaap DividendsPayableAmountPerShare Dividends Payable, Amount Per Share USD/shares 0.5 2015-06-30 2016 Q2 10-Q 2016-08-10 0001144204-16-118076
us-gaap DividendsPayableCurrent Dividends Payable, Current USD 1.27M 2024-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap DividendsPayableCurrentAndNoncurrent Dividends Payable USD 0 2020-09-30 2020 Q3 10-Q 2020-11-09 0001104659-20-123067
us-gaap DividendsPreferredStockStock Dividends, Preferred Stock, Stock USD 531,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-10 0001410578-24-000735
us-gaap DueFromRelatedPartiesCurrent Due from Related Parties, Current USD 111,000 2017-12-31 2017 FY 10-K 2018-03-21 0001144204-18-016199
us-gaap DueToRelatedPartiesCurrentAndNoncurrent Due to Related Parties USD 306,000 2020-09-30 2020 Q3 10-Q 2020-11-09 0001104659-20-123067
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.49 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.01 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-05 0001104659-21-100764
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.49 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.064 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0.781 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.245 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 1 2021-01-01 2021-12-31 2019 Q3 10-Q 2019-11-06 0001104659-19-060500
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -208,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 3.10M 2012-12-31 2012 FY 10-K 2013-03-18 0001144204-13-015878
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount USD 800,000 2013-09-30 2013 Q3 10-Q 2013-11-12 0001144204-13-060539
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 0 2022-12-31 2022 FY 10-K 2023-02-16 0001410578-23-000136
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 12.20M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap ForeignIncomeTaxExpenseBenefitContinuingOperations Foreign Income Tax Expense (Benefit), Continuing Operations USD 33,000 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-09 0001144204-12-060778
us-gaap FutureMinimumSubleaseRentalsSaleLeasebackTransactions Future Minimum Sublease Rentals, Sale Leaseback Transactions USD 2.31M 2013-12-31 2014 FY 10-K 2015-03-05 0001144204-15-014238
us-gaap FutureMinimumSubleaseRentalsSaleLeasebackTransactionsThereafter Future Minimum Sublease Rentals, Sale Leaseback Transactions, Thereafter USD 1.08M 2013-12-31 2014 FY 10-K 2015-03-05 0001144204-15-014238
us-gaap FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinFourYears Future Minimum Sublease Rentals, Sale Leaseback Transactions, within Four Years USD 420,000 2013-12-31 2014 FY 10-K 2015-03-05 0001144204-15-014238
us-gaap FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear Future Minimum Sublease Rentals, Sale Leaseback Transactions, Next Twelve Months USD 193,000 2013-12-31 2014 FY 10-K 2015-03-05 0001144204-15-014238
us-gaap FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears Future Minimum Sublease Rentals, Sale Leaseback Transactions, within Three Years USD 356,000 2013-12-31 2014 FY 10-K 2015-03-05 0001144204-15-014238
us-gaap FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears Future Minimum Sublease Rentals, Sale Leaseback Transactions, within Two Years USD 258,000 2013-12-31 2014 FY 10-K 2015-03-05 0001144204-15-014238
us-gaap GainLossOnContractTermination Gain (Loss) on Contract Termination USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-21 0001144204-18-016199
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-21 0001144204-16-089172
us-gaap GainLossOnDispositionOfProperty Gain (Loss) on Disposition of Property (Deprecated 2013-01-31) USD -61,000 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-11-04 0000930413-11-006994
us-gaap GainLossOnRepurchaseOfDebtInstrument Gain (Loss) on Repurchase of Debt Instrument USD 212,000 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-09 0001144204-12-060778
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-12 0001144204-13-060539
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 26.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap Goodwill Goodwill USD 3.04M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap GrossProfit Gross Profit USD 28.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap ImpairmentOfInvestments Other than Temporary Impairment Losses, Investments USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-18 0001144204-13-015878
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-05 0001144204-15-014238
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 9.60M 2025-01-01 2025-03-31 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD -2.78M 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-18 0001144204-13-015878
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -3.39M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -17.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -2.78M 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-18 0001144204-13-015878
us-gaap IncomeLossFromContinuingOperationsPerBasicAndDilutedShare Income (Loss) from Continuing Operations, Per Basic and Diluted Share USD/shares -0.06 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-18 0001144204-13-015878
us-gaap IncomeLossFromContinuingOperationsPerBasicShare Income (Loss) from Continuing Operations, Per Basic Share USD/shares -0.11 2012-10-01 2012-12-31 2012 FY 10-K 2013-03-18 0001144204-13-015878
us-gaap IncomeLossFromContinuingOperationsPerDilutedShare Income (Loss) from Continuing Operations, Per Diluted Share USD/shares -0.11 2012-10-01 2012-12-31 2012 FY 10-K 2013-03-18 0001144204-13-015878
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-18 0001144204-13-015878
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share USD/shares 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-18 0001144204-13-015878
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share USD/shares 0 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-11-04 0000930413-11-006994
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share USD/shares 0 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-11-04 0000930413-11-006994
us-gaap IncomeTaxesPaid Income Taxes Paid USD 0 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001104659-25-110410
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 3.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap IncomeTaxesReceivable Income Taxes Receivable, Current USD 485,000 2019-12-31 2020 FY 10-K 2021-02-23 0001104659-21-026712
us-gaap IncomeTaxesReceivableNoncurrent Income Taxes Receivable, Noncurrent USD 485,000 2019-12-31 2020 FY 10-K 2021-02-23 0001104659-21-026712
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 1.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap IncomeTaxExpenseBenefitContinuingOperations Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) USD -4.13M 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-18 0001144204-13-015878
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 2,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 11.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-21 0001144204-19-009301
us-gaap IncomeTaxReconciliationDispositionOfBusiness Effective Income Tax Rate Reconciliation, Disposition of Business, Amount USD 4.50M 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-24 0001144204-17-016511
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -712,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 831,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-23 0001104659-21-026712
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -1,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap IncomeTaxReconciliationRepatriationOfForeignEarnings Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-21 0001144204-16-089172
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 6,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-14 0001144204-14-015753
us-gaap IncomeTaxReconciliationTaxExemptIncome Effective Income Tax Rate Reconciliation, Tax Exempt Income, Amount USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-21 0001144204-19-009301
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -4.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap IncreaseDecreaseInAccountsPayableTrade Increase (Decrease) in Accounts Payable, Trade USD 29,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-02-16 0001410578-23-000136
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 11.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 4.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap IncreaseDecreaseInDeferredIncomeTaxes Increase (Decrease) in Deferred Income Taxes USD 15.90M 2017-01-01 2017-12-31 2018 FY 10-K 2019-02-21 0001144204-19-009301
us-gaap IncreaseDecreaseInEmployeeRelatedLiabilities Increase (Decrease) in Employee Related Liabilities USD -381,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 6.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap IncreaseDecreaseInLongTermReceivablesCurrent Increase (Decrease) in Long-term Receivables, Current USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-25 0001410578-22-000226
us-gaap IncreaseDecreaseInOperatingCapital Increase (Decrease) in Operating Capital USD 583,000 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-06 0001144204-14-065728
us-gaap IncreaseDecreaseInOtherAccruedLiabilities Increase (Decrease) in Other Accrued Liabilities USD 328,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD 6.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD -1.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 23,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-25 0001410578-22-000226
us-gaap IncreaseDecreaseInOtherOperatingCapitalNet Increase (Decrease) in Other Operating Assets and Liabilities, Net USD -19,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001104659-25-110410
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD -492,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 0 2025-04-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001410578-25-001810
us-gaap IncrementalCommonSharesAttributableToConversionOfDebtSecurities Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities shares 0 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-06 0001144204-14-065728
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 0 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-10 0001144204-18-043614
us-gaap InterestExpense Interest Expense USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-05 0001144204-15-014238
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD -8.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap InterestOnConvertibleDebtNetOfTax Interest on Convertible Debt, Net of Tax USD 0 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-06 0001144204-14-065728
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 2.30M 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-12 0001144204-13-060539
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 7.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap InterestPayableCurrent Interest Payable, Current USD 0 2013-12-31 2013 FY 10-K 2014-03-14 0001144204-14-015753
us-gaap InventoryAdjustments Inventory Adjustments USD 4.09M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 30.81M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap InventoryNet Inventory, Net USD 100.34M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 29.27M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 40.25M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap InventoryWriteDown Inventory Write-down USD 2.50M 2025-01-01 2025-03-31 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap InvestmentIncomeNet Investment Income, Net USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-21 0001144204-16-089172
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 708,000 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-07 0001144204-19-038191
us-gaap LeaseholdImprovementsGross Leasehold Improvements, Gross USD 1.09M 2012-12-31 2013 FY 10-K 2014-03-14 0001144204-14-015753
us-gaap Liabilities Liabilities USD 4.80M 2015-12-31 2015 FY 10-K 2016-03-21 0001144204-16-089172
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 427.47M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap LiabilitiesCurrent Liabilities, Current USD 210.73M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap LiabilityForUncertainTaxPositionsNoncurrent Liability for Uncertainty in Income Taxes, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap LongTermDebt Long-term Debt USD 135.71M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 135.71M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 84.38M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 49.60M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 74.93M 2026-06-30 2026 Q2 10-Q 2026-08-03 0001104659-26-089804
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 115.85M 2012-12-31 2013 FY 10-K 2014-03-14 0001144204-14-015753
us-gaap MachineryAndEquipmentGross Machinery and Equipment, Gross USD 24.08M 2012-12-31 2013 FY 10-K 2014-03-14 0001144204-14-015753
us-gaap MarketableSecurities Marketable Securities USD 0 2019-12-31 2019 FY 10-K 2020-02-19 0001104659-20-022802
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 0 2013-12-31 2013 FY 10-K 2014-03-14 0001144204-14-015753
us-gaap MarketableSecuritiesGainLoss Marketable Securities, Gain (Loss) USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-05 0001144204-15-014238
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 0 2012-12-31 2012 FY 10-K 2013-03-18 0001144204-13-015878
us-gaap MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss USD 900,000 2010-01-01 2010-12-31 2012 FY 10-K 2013-03-18 0001144204-13-015878
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD -1.62M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap MoneyMarketFundsAtCarryingValue Money Market Funds, at Carrying Value USD 115.20M 2012-09-30 2012 Q3 10-Q 2012-11-09 0001144204-12-060778
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 49.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD -6.63M 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-24 0001144204-17-016511
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -23.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-21 0001144204-16-089172
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -27.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD 3.57M 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-10 0001144204-17-042058
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -18.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD -141,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap NetIncomeLossAttributableToParentDiluted Net Income (Loss) Attributable to Parent, Diluted USD 23.00M 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-06 0001144204-14-065728
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -18.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -18.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap NoncurrentAssets Long-Lived Assets USD 180.23M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap NotesPayable Notes Payable USD 115.85M 2013-03-31 2013 Q1 10-Q 2013-05-10 0001144204-13-027985
us-gaap NotesPayableCurrent Notes Payable, Current USD 0 2013-12-31 2013 FY 10-K 2014-03-14 0001144204-14-015753
us-gaap NotesPayableFairValueDisclosure Notes Payable, Fair Value Disclosure USD 117.08M 2012-12-31 2013 FY 10-K 2014-03-14 0001144204-14-015753
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 4 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 4 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap OperatingExpenses Operating Expenses USD 5.31M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -9.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 729 2020-06-30 2020 Q2 10-Q 2020-07-29 0001104659-20-087796
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 4.18M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 15.03M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 17.01M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 4.92M 2013-12-31 2014 FY 10-K 2015-03-05 0001144204-15-014238
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 703,000 2013-12-31 2014 FY 10-K 2015-03-05 0001144204-15-014238
us-gaap OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals USD 2.49M 2013-09-30 2013 Q3 10-Q 2013-11-12 0001144204-13-060539
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 394,000 2013-09-30 2013 Q3 10-Q 2013-11-12 0001144204-13-060539
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 774,000 2013-12-31 2014 FY 10-K 2015-03-05 0001144204-15-014238
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 742,000 2013-12-31 2014 FY 10-K 2015-03-05 0001144204-15-014238
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 703,000 2013-12-31 2014 FY 10-K 2015-03-05 0001144204-15-014238
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 2.00M 2013-12-31 2014 FY 10-K 2015-03-05 0001144204-15-014238
us-gaap OperatingLeasesFutureMinimumPaymentsReceivable Operating Leases, Future Minimum Payments Receivable USD 400,000 2012-12-31 2012 FY 10-K 2013-03-18 0001144204-13-015878
us-gaap OperatingLeasesIncomeStatementSubleaseRevenue Operating Leases, Income Statement, Sublease Revenue USD 42,000 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-21 0001144204-18-016199
us-gaap OperatingLeasesRentExpenseSubleaseRentals1 Operating Leases, Rent Expense, Sublease Rentals USD 400,000 2010-07-01 2010-09-30 2012 FY 10-K 2013-03-18 0001144204-13-015878
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 101.90M 2025-03-31 2025 Q1 10-Q 2025-05-09 0001410578-25-001164
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 9,000 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap OtherAssetsCurrent Other Assets, Current USD 48.25M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap OtherAssetsMiscellaneousCurrent Other Assets, Miscellaneous, Current USD 4.41M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 7.61M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-18 0001144204-13-015878
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax (Deprecated 2012-01-31) USD -742,000 2010-01-01 2010-12-31 2011 FY 10-K 2012-03-12 0000930413-12-001483
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment and Tax USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-05 0001144204-15-014238
us-gaap OtherComprehensiveIncomeLossBeforeTax Other Comprehensive Income (Loss), before Tax USD -3.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -3.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -3.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest USD -141,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-05 0001144204-15-014238
us-gaap OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax USD 502,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, Net of Tax (Deprecated 2013-01-31) USD -281,000 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-10 0001144204-13-027985
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax USD 0 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-06 0001144204-14-065728
us-gaap OtherComprehensiveIncomeLossTax Other Comprehensive Income (Loss), Tax USD -71,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-04 0001104659-26-054911
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax USD 237,000 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-14 0001144204-14-015753
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-05 0001144204-15-014238
us-gaap OtherGeneralAndAdministrativeExpense Other General and Administrative Expense USD 1.36M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap OtherInterestAndDividendIncome Other Interest and Dividend Income USD 1.92M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 0 2012-12-31 2012 FY 10-K 2013-03-18 0001144204-13-015878
us-gaap OtherMarketableSecuritiesCurrent Other Marketable Securities, Current (Deprecated 2018-01-31) USD 2.50M 2011-12-31 2012 Q3 10-Q 2012-11-09 0001144204-12-060778
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-14 0001144204-14-015753
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 646,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-16 0001410578-23-000136
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 780,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 3.50M 2017-12-31 2017 FY 10-K 2018-03-21 0001144204-18-016199
us-gaap OtherRestructuringCosts Other Restructuring Costs USD 775,000 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-14 0001144204-14-015753
us-gaap OtherSalesRevenueNet Other Revenue, Net (Deprecated 2018-01-31) USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-21 0001144204-18-016199
us-gaap OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent Other than Temporary Impairment Losses, Investments, Portion in Other Comprehensive Loss, before Tax, Portion Attributable to Parent USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-18 0001144204-13-015878
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-14 0001144204-14-015753
us-gaap PaymentsForRestructuring Payments for Restructuring USD 867,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap PaymentsOfDividendsCommonStock Payments of Ordinary Dividends, Common Stock USD 1.27M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 2.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-25 0001410578-22-000226
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-24 0001144204-17-016511
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-14 0001144204-14-015753
us-gaap PaymentsToAcquireProductiveAssets Payments to Acquire Productive Assets USD 23.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-14 0001144204-14-015753
us-gaap PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent Liability, Pension and Other Postretirement and Postemployment Benefits, Current USD 0 2014-12-31 2014 FY 10-K 2015-03-05 0001144204-15-014238
us-gaap PreferredStockDividendsIncomeStatementImpact Preferred Stock Dividends, Income Statement Impact USD 2.12M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.01 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 2.96M 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2022-06-30 2022 Q2 10-Q 2022-08-04 0001410578-22-002040
us-gaap ProceedsFromDivestitureOfBusinesses Proceeds from Divestiture of Businesses USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-18 0001144204-13-015878
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 15.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 647,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-03 0001104659-26-089804
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-05 0001144204-15-014238
us-gaap ProceedsFromRepaymentsOfNotesPayable Proceeds from (Repayments of) Notes Payable USD -115.85M 2013-01-01 2013-06-30 2013 Q2 10-Q 2013-08-06 0001144204-13-043344
us-gaap ProceedsFromRoyaltiesReceived Proceeds from Royalties Received USD 115,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-02-23 0001104659-21-026712
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-05 0001144204-15-014238
us-gaap ProceedsFromSaleOfIntangibleAssets Proceeds from Sale of Intangible Assets USD 700,000 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-10 0001144204-13-027985
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-21 0001144204-16-089172
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-21 0001410578-25-000177
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 0 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-06 0001144204-14-065728
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -18.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap ProFormaWeightedAverageSharesOutstandingDiluted Pro Forma Weighted Average Shares Outstanding, Diluted shares 742,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 503.41M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 155.59M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-05 0001144204-15-014238
us-gaap RepaymentsOfShortTermDebt Repayments of Short-term Debt USD 4.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned Research and Development Arrangement, Contract to Perform for Others, Compensation Earned USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-14 0001144204-14-015753
us-gaap ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-14 0001144204-14-015753
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 1.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 50.50M 2012-12-31 2013 FY 10-K 2014-03-14 0001144204-14-015753
us-gaap RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated Restructuring and Related Cost, Expected Number of Positions Eliminated Employees 4 2013-07-01 2013-09-30 2013 Q3 10-Q 2013-11-12 0001144204-13-060539
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminated Restructuring and Related Cost, Number of Positions Eliminated employee 210 2025-01-01 2025-12-31 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap RestructuringCharges Restructuring Charges USD 714,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap RestructuringReserve Restructuring Reserve USD 153,000 2025-12-31 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap RestructuringReserveAccrualAdjustment Restructuring Reserve, Accrual Adjustment (Deprecated 2016-01-31) USD 268,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-21 0001144204-16-089172
us-gaap RestructuringReserveCurrent Restructuring Reserve, Current USD 503,000 2013-09-30 2014 Q3 10-Q 2014-11-06 0001144204-14-065728
us-gaap RestructuringReserveNoncurrent Restructuring Reserve, Noncurrent USD 291,000 2013-09-30 2014 Q3 10-Q 2014-11-06 0001144204-14-065728
us-gaap RestructuringReserveSettledWithCash Restructuring Reserve, Settled With Cash (Deprecated 2013-01-31) USD -3.40M 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-09 0001144204-12-060778
us-gaap RetainageDeposit Retainage Deposit USD 259 2019-08-31 2020 Q2 10-Q 2020-07-29 0001104659-20-087796
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -30.04M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 271.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap RevenueRecognitionMilestoneMethodRevenueRecognized Revenue Recognition, Milestone Method, Revenue Recognized USD 27.00M 2010-01-01 2010-12-31 2015 FY 10-K 2016-03-21 0001144204-16-089172
us-gaap Revenues Revenues USD 26,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap RoyaltyIncomeNonoperating Royalty Income, Nonoperating USD 54,000 2018-07-01 2018-09-30 2018 Q3 10-Q 2018-11-07 0001144204-18-057974
us-gaap RoyaltyRevenue Royalty Revenue (Deprecated 2018-01-31) USD 15,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001144204-18-027186
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 15,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001144204-18-027186
us-gaap SecurityDeposit Security Deposit USD 259 2019-08-31 2020 Q2 10-Q 2020-07-29 0001104659-20-087796
us-gaap SegmentExpenditureAdditionToLongLivedAssets SegmentExpenditureAdditionToLongLivedAssets USD 23.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap SellingAndMarketingExpense Selling and Marketing Expense USD 7.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 35.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap SeveranceCosts Severance Costs (Deprecated 2013-01-31) USD 900,000 2012-01-01 2012-12-31 2013 Q1 10-Q 2013-05-10 0001144204-13-027985
us-gaap SeveranceCosts1 Severance Costs USD 52,000 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-21 0001144204-18-016199
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-05 0001144204-15-014238
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-21 0001144204-16-089172
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-21 0001144204-16-089172
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-09 0001410578-22-003068
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-21 0001144204-16-089172
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 0 2021-09-30 2021 Q3 10-Q 2021-11-05 0001410578-21-000030
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 0 2015-12-31 2015 FY 10-K 2016-03-21 0001144204-16-089172
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 45,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-21 0001144204-16-089172
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value USD -100,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-21 0001144204-16-089172
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 2.55 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-21 0001144204-16-089172
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.343 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-05 0001144204-15-014238
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.008 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-05 0001144204-15-014238
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 17,339 2012-09-30 2013 FY 10-K 2014-03-14 0001144204-14-015753
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2021-12-31 2021 FY 10-K 2022-02-25 0001410578-22-000226
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 0 2022-09-30 2022 Q3 10-Q 2022-11-09 0001410578-22-003068
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 1.31 2021-12-31 2021 FY 10-K 2022-02-25 0001410578-22-000226
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-14 0001144204-14-015753
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-16 0001410578-23-000136
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 25,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-09 0001410578-22-003068
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-21 0001144204-18-016199
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 221,000 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-14 0001144204-14-015753
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-16 0001410578-23-000136
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-09 0001410578-22-003068
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-21 0001144204-18-016199
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 0 2019-12-31 2019 FY 10-K 2020-02-19 0001104659-20-022802
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 0 2021-12-31 2021 FY 10-K 2022-02-25 0001410578-22-000226
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 0 2023-03-31 2023 Q1 10-Q 2023-05-05 0001410578-23-000888
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 1.31 2021-12-31 2021 FY 10-K 2022-02-25 0001410578-22-000226
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 0 2021-12-31 2021 FY 10-K 2022-02-25 0001410578-22-000226
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 0 2022-09-30 2022 Q3 10-Q 2022-11-09 0001410578-22-003068
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 1.31 2021-12-31 2021 FY 10-K 2022-02-25 0001410578-22-000226
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-21 0001144204-18-016199
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 1.31 2021-01-01 2021-12-31 2022 FY 10-K 2023-02-16 0001410578-23-000136
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 3.03 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-14 0001144204-14-015753
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-21 0001144204-18-016199
us-gaap SharePrice Share Price USD/shares 1 2016-08-09 2016 Q3 10-Q 2016-11-10 0001144204-16-133295
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 0.58 2026-01-31 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap ShortTermBorrowings Short-term Debt USD 135.71M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap ShortTermInvestments Short-term Investments USD 41.08M 2011-06-30 2011 Q2 10-Q 2011-08-05 0000930413-11-005153
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 178.94M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 177.32M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.01 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 1.27M 2026-01-01 2026-01-31 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-09 0001410578-22-003068
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 39.98M 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 114.75M 2010-01-01 2010-12-31 2012 FY 10-K 2013-03-18 0001144204-13-015878
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 12,000 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-05 0001144204-15-014238
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 15.00M 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 1.92M 2011-01-01 2011-12-31 2011 FY 10-K 2012-03-12 0000930413-12-001483
us-gaap StockIssuedDuringPeriodValueShareBasedCompensationGross Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture USD 6,000 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-24 0001144204-17-016511
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 5.45M 2011-01-01 2011-12-31 2013 FY 10-K 2014-03-14 0001144204-14-015753
us-gaap StockOptionPlanExpense Stock or Unit Option Plan Expense USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-21 0001144204-18-016199
us-gaap StockRepurchasedAndRetiredDuringPeriodShares Stock Repurchased and Retired During Period, Shares shares 16.17M 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-21 0001144204-16-089172
us-gaap StockRepurchasedAndRetiredDuringPeriodValue Stock Repurchased and Retired During Period, Value USD 153.40M 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-21 0001144204-16-089172
us-gaap StockRepurchaseProgramAuthorizedAmount Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) USD 200.00M 2010-12-01 2010-12-21 2014 Q1 10-Q 2014-05-09 0001144204-14-029062
us-gaap StockRepurchaseProgramAuthorizedAmount1 Stock Repurchase Program, Authorized Amount USD 200.00M 2010-12-21 2015 FY 10-K 2016-03-21 0001144204-16-089172
us-gaap Supplies Prepaid Supplies USD 19.61M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap TangibleAssetImpairmentCharges Tangible Asset Impairment Charges USD 362,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap TaxCreditCarryforwardAmount Tax Credit Carryforward, Amount USD 14.80M 2020-12-31 2020 FY 10-K 2021-02-23 0001104659-21-026712
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 433,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap TemporaryEquityLiquidationPreferencePerShare Temporary Equity, Liquidation Preference Per Share USD/shares 1,129 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 3.00M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 384 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 384 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap TemporaryEquityStockIssuedDuringPeriodValueNewIssues Temporary Equity, Stock Issued During Period, Value, New Issues USD 40.00M 2020-10-01 2020-10-31 2024 Q1 10-Q 2024-05-10 0001410578-24-000735
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 0 2004-12-31 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap UnamortizedDebtIssuanceExpense Unamortized Debt Issuance Expense USD 200,000 2012-12-31 2013 Q3 10-Q 2013-11-12 0001144204-13-060539
us-gaap ValuationAllowanceAmount Valuation Allowance, Amount (Deprecated 2013-01-31) USD 102.10M 2012-12-31 2012 FY 10-K 2013-03-18 0001144204-13-015878
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 11.11M 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-21 0001144204-16-089172
us-gaap WeightedAverageBasicSharesOutstandingProForma Weighted Average Basic Shares Outstanding, Pro Forma shares 742,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001104659-26-022313
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 11,631 2025-01-01 2025-12-31 2026 Q2 10-Q 2026-08-03 0001104659-26-089804
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 12.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 74,215 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-04 0001104659-21-060966
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 12.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001104659-26-121529
us-gaap WriteOffOfDeferredDebtIssuanceCost Write off of Deferred Debt Issuance Cost USD 62,000 2012-01-01 2012-12-31 2013 Q3 10-Q 2013-11-12 0001144204-13-060539

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →